Puma Biotechnology Inc (PBYI) financials · rev $228.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Puma Biotechnology Inc (PBYI) rev $228.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $228.4M | $230.5M |
| Cost of Revenue | $58.2M | $64.4M |
| Gross Profit | $170.2M | $166.1M |
| Operating Income | $37.3M | $31.0M |
| Net Income | $31.1M | $30.3M |
| EPS (Diluted) | $0.61 | $0.62 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $216.3M | $213.3M |
| Current Assets | $162.7M | $147.7M |
| Cash & Equivalents | $29.6M | $69.2M |
| Inventory | $5.51M | $8.72M |
| PP&E | $187.0K | $515.0K |
| Total Liabilities | $86.0M | $121.2M |
| Current Liabilities | $81.3M | $96.1M |
| Short-term Debt | $22.5M | $45.3M |
| Long-term Debt | N/A | $21.7M |
| Total Debt | $22.5M† | $67.0M† |
| Shareholders' Equity | $130.3M | $92.1M |
| Retained Earnings | -$1.28B | -$1.31B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $41.8M | $38.9M |
| CapEx | $71.0K | $56.0K |
| Investing Cash Flow | -$36.2M | -$20.4M |
| Financing Cash Flow | -$45.2M | -$33.8M |
| Net Change in Cash | -$39.6M | -$15.4M |
| Free Cash Flow | $41.7M | $38.9M |
FAQ
What is PBYI P/E and revenue?
Puma Biotechnology Inc (PBYI) rev $228.4M.
What is PBYI revenue?
Puma Biotechnology Inc last cached revenue is $228.4M (FY2025).
Is PBYI profitable?
Puma Biotechnology Inc last cached net income is $31.1M (FY2025).
What are PBYI total assets?
Puma Biotechnology Inc last cached total assets are $216.3M (FY2025).
What is PBYI free cash flow?
Puma Biotechnology Inc last cached free cash flow is $41.7M (FY2025).
Not investment advice. Cached statements, not a live tape.